SEC reporting owner

STEINMETZ MICHAEL SEC insider disclosures

Explore STEINMETZ MICHAEL's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001166285
Issuers
33
Coverage
verified

Inspect this reporting owner's activity

Step 1 of 3

Issuer relationships

STEINMETZ MICHAEL: source evidence dated 2026-10-07T00:29:11.873Z.

Issuer
ACORDA THERAPEUTICS INC
CIK
0001008848
Tickers
ACOR
Officer
No
Director
Yes
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Which issuer and transaction does this person appear in?

Match the reviewed owner identity, issuer and transaction code. Directory eligibility does not turn every filing into a strategy signal.

What you should see

Use the linked SEC receipts and company profiles to verify what became public and when.

Step 3 of 3

Browse insider directory

Use the linked SEC receipts and company profiles to verify what became public and when.

Browse insider directory
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Issuer relationships

See the complete issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

ACORDA THERAPEUTICS INC0001008848ACORNoYes
Omrix Biopharmaceuticals, Inc.0001349426OMRINoNo
PONIARD PHARMACEUTICALS, INC.0000755806NERX, PARDNoNo
Restore Medical, Inc.0001350620RESTNoNo
AFFYMAX INC0001158223AFFYNoNo
COTHERIX INC0001138812CTRXNoNo
VIACELL INC0001114529VIACNoNo
CRITICAL THERAPEUTICS INC0001145404CRTXNoNo
SENORX INC0001097136SENONoNo
CRYOCOR INC0001125294CRYONoNo
Pharmasset Inc0001301081VRUSNoNo
Somaxon Pharmaceuticals, Inc.0001339455SOMXNoNo
HELICOS BIOSCIENCES CORP0001274563HLCSNoNo
Alsius Corp0001324205ITHKNoNo
PHARMATHENE, INC0001326190HAQ, PIPNoNo
HEMOSENSE INC0001127393HEMNoNo
ARYx Therapeutics, Inc.0001410064ARYXNoNo
EnteroMedics Inc0001371217ETRMNoNo
AVANIR PHARMACEUTICALS, INC.0000858803AVNRNoNo
METABASIS THERAPEUTICS INC0001053221MBRXNoNo
ACHILLION PHARMACEUTICALS INC0001070336ACHNNoNo
OSCIENT PHARMACEUTICALS CORP0000356830OSCINoNo
Zalicus Inc.0001135906CRXX, ZLCSNoNo
AVEO PHARMACEUTICALS INC0001325879AVEONoNo
ZOGENIX, INC.0001375151ZGNXNoNo
Radius Health, Inc.0001428522RDUSNoNo
GLOBUS MEDICAL INC0001237831GMEDNoNo
KALOBIOS PHARMACEUTICALS INC0001293310KBIONoNo
Ophthotech Corp.0001410939OPHTNoNo
AERIE PHARMACEUTICALS INC0001337553AERINoNo
Oxford Immunotec Global PLC0001586049OXFDNoYes
TETRALOGIC PHARMACEUTICALS CORP0001361248TLOGNoYes
VBI VACCINES INC.0000704159VBIVNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.